Month: July 2020

Nuclei, a leading provider of digital and lifestyle banking solutions, has entered into a partnership with SafeGold, India’s largest digital gold platform provider. Through this collaboration, Nuclei can now seamlessly connect Digital Gold solution by SafeGold to the mobile app of any Bank. This will enable the customers to purchase and sell 24K physical gold online, for as low as INR 1, from their own Banking platform. Post the outbreak of the coronavirus, more consumers are leaning towards traditional investments which are less volatile and safer. One of such option is Gold which has been a preferred investment product for the Indian audience for a very long time. Customers aspiring for greater convenience, are now looking towards their trustworthy banking platforms as a one stop shop for all their requirements, both financial and non-financial....

Amsterdam, 16 July 2020 – Heineken Holding N.V. (EURONEXT: HEIO; OTCQX: HKHHY) today issued the following statement.  In the first half of 2020, HEINEKEN’s markets and businesses were significantly impacted by the COVID-19 pandemic, with unprecedented volatility and uncertainty leading to the withdrawal of guidance for 2020 on 8 April. Despite these short-term challenges, HEINEKEN remains confident in its ability to navigate the crisis while continuing to build a bright future.In this context, HEINEKEN has decided to disclose preliminary highlights of its 2020 half-year results ahead of the scheduled publication date. The final results will be published as planned on 3 August 2020. All figures mentioned below are preliminary, unaudited and may be subject to adjustments from customary reviews.Based on preliminary figures, first-half net...

NEW YORK and LONDON, July 16, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, is pleased to announce that it has submitted a patent application on potential use of Foralumab, a fully human anti-CD3 monoclonal antibody (mAb), to improve success of CAR-T therapy for cancer and other human diseases. The patent application conveys inventions related to improving CAR-T expansion and/or survival using anti-CD-3 mAbs administered either alone or in combination with other co-stimulatory molecules, such as an anti-IL-6 receptor monoclonal antibody, an anti-CD28 monoclonal antibody or specific inhibitors of signaling pathways of phosphatidylinositol 3-kinase (PI3K), protein...

Press releaseNotice of Bergman & Beving’s Annual General Meeting on 26 August 2020Shareholders in Bergman & Beving AB (publ), Corporate Registration Number 556034-8590 (the “Company” or “Bergman & Beving”), are hereby given notice to attend the Annual General Meeting on 26 August 2020, at 4:00 p.m. CET at IVA Conference Centre, Grev Turegatan 16, Stockholm, Sweden. Registration for the Meeting will begin at 3:15 p.m. CET.NOTICE OF PARTICIPATIONShareholders who wish to participate in the proceedings of the Annual General Meeting must:be recorded in the shareholders’ register maintained by Euroclear Sweden AB on the record date on 20 August 2020, and by 20 August 2020 the latest, file notice of their intention to participate via the link on the Company’s website, by post to Bergman & Beving Aktiebolag, “Annual General...

PressmeddelandeKallelse till Bergman & Bevings årsstämma den 26 augusti 2020Aktieägarna i Bergman & Beving AB (publ), org.nr 556034-8590 (”Bolaget” eller ”Bergman & Beving”), kallas härmed till årsstämma den 26 augusti 2020 klockan 16:00 på IVA Konferenscenter, Grev Turegatan 16 i Stockholm. Inregistrering till stämman påbörjas klockan 15:15.ANMÄLAN OM DELTAGANDEAktieägare som önskar delta i årsstämman ska:dels vara införd i den av Euroclear Sweden AB förda aktieboken på avstämningsdagen som är den 20 augusti 2020 dels senast den 20 augusti 2020 anmäla sig via länk på Bolagets hemsida, per post under adress: Bergman & Beving Aktiebolag, ”Årsstämma”, c/o Euroclear Sweden, Box 191, 101 23 Stockholm eller per telefon 08-402 90 66 (klockan 09:00-16:00). Vid anmälan ska aktieägare uppge namn, personnummer (organisationsnummer),...

Alstom Q1 2020/21 Orders and SalesSales at €1.5 billion, impacted by Covid-19 containment measuresSustained level of order intake at €1.7 billion, despite crisisIndustry-leading backlog at €41.2 billionRail resilience supported by recent announcements in favour of sustainable mobility16 July 2020 – Over the first quarter of the 2020/21 fiscal year (from 1 April to 30 June 2020), Alstom booked €1.7 billion of orders, compared to €1.6 billion over the same period last year. The Group’s sales decreased to €1.5 billion, down 27% (-25% on an organic basis) compared to €2.1 billion over the first quarter of 2019/20. Book-to-bill ratio stood at 1.1.At €41.2 billion on 30 June 2020, the current backlog provides a strong indication of future sales.Key figuresGeographic and product breakdowns of reported orders and sales are provided in Appendix...

Les commandes et le chiffre d’affaires d’Alstomau premier trimestre 2020/21Un chiffre d’affaires à 1,5 milliard d’euros, impacté par les mesures de confinement liées au Covid-19Une prise de commandes qui se maintient, à 1,7 milliard d’euros malgré la crise Le carnet de commandes le plus important du secteur à 41,2 milliards d’eurosLe rail résilient, soutenu par les annonces récentes en faveur de la mobilité durable 16 juillet 2020 – Au cours du premier trimestre 2020/21 (du 1er avril au 30 juin 2020), Alstom a enregistré 1,7 milliard d’euros de commandes, contre 1,6 milliard d’euros sur la même période l’année précédente. Le chiffre d’affaires du Groupe s’est établi à 1,5 milliard d’euros, en baisse de 27 % (-25 % à périmètre et taux de change constants) comparé aux 2,1 milliards d’euros du premier trimestre 2019/20. Le ratio commandes...